These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27396813)

  • 1. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis.
    Li X; Wu XQ; Xu T; Li XF; Yang Y; Li WX; Huang C; Meng XM; Li J
    Toxicol Appl Pharmacol; 2016 Sep; 306():58-68. PubMed ID: 27396813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
    Wang Y; Zhao L; Jiao FZ; Zhang WB; Chen Q; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):423-429. PubMed ID: 30249543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.
    You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J
    FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
    Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
    Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells.
    Chen PJ; Cai SP; Yang Y; Li WX; Huang C; Meng XM; Li J
    Toxicol Appl Pharmacol; 2016 Feb; 292():8-18. PubMed ID: 26739621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis.
    Chen PJ; Huang C; Meng XM; Li J
    Biochimie; 2015 Sep; 116():61-9. PubMed ID: 26116886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
    Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
    Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis.
    Li M; Zheng Y; Yuan H; Liu Y; Wen X
    Int Immunopharmacol; 2017 Nov; 52():272-280. PubMed ID: 28961490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
    Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
    J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
    Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
    Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
    Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
    PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells.
    Yang Y; Bae M; Park YK; Lee Y; Pham TX; Rudraiah S; Manautou J; Koo SI; Lee JY
    J Nutr Biochem; 2017 Feb; 40():172-177. PubMed ID: 27915160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.
    Zhang YQ; Wan LY; He XM; Ni YR; Wang C; Liu CB; Wu JF
    DNA Cell Biol; 2017 Jul; 36(7):603-610. PubMed ID: 28467108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cell-specific deletion of SIRT1 exacerbates liver fibrosis in mice.
    Li M; Hong W; Hao C; Li L; Xu H; Li P; Xu Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3202-3211. PubMed ID: 28919365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.
    Bai X; Wu L; Liang T; Liu Z; Li J; Li D; Xie H; Yin S; Yu J; Lin Q; Zheng S
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):83-91. PubMed ID: 17611778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.